Neurimmune achieves milestone with Ono Pharmaceutical

Neurimmune has announced the achievement of a key preclinical milestone in the ongoing collaboration with Ono Pharmaceut...

September 18, 2018 | Tuesday | News
New AI tool accurately identifies lung cancer type

Singapore - A new computer program can analyze images of patients' lung tumors, specify cancer types, and even identify ...

September 18, 2018 | Tuesday | News
BioCity wins contract to provide support to Scottish companies

Life sciences incubator, BioCity, has won a contract tendered by Scottish Enterprise to provide specialist support and a...

September 18, 2018 | Tuesday | News
Canadian researchers to convert any blood group to Type O

A team of researchers from the University of British Columbia, Canada has isolated an enzyme in the gut that reliably co...

September 18, 2018 | Tuesday | News
Accenture, Merck, Amazon partner to advance drug innovation and research

Accenture and Merck, known as MSD outside the United States and Canada, in collaboration with Amazon Web Services (AWS),...

September 18, 2018 | Tuesday | News
NIH to accelerate genetic therapies for sickle cell disease

The National Institutes of Health (NIH) has announced the launch of a new initiative to help speed the development of cu...

September 17, 2018 | Monday | News
Rostec to build unique oncology treatment centre in Russian Far East

State Corporation Rostec and the administration of the Primorsky Krai, a federal subject in the Russian Far East, have s...

September 14, 2018 | Friday | News
Cigna launches $250 M venture fund

Health services organization Cigna has launched Cigna Ventures, a corporate venture fund with an infusion of $250 millio...

September 14, 2018 | Friday | News
IFC invests $40 M in Fullerton Health

Singapore – Fullerton Healthcare Corporation announced that its wholly owned subsidiaries, Fullerton Health P...

September 13, 2018 | Thursday | News
Systech, FarmaTrust to deliver foolproof pharma Blockchain solution

Systech, a global technology leader in brand protection and product authentication, and FarmaTrust, a leader in pharmace...

September 12, 2018 | Wednesday | News
Manchester team develops non-antibiotic drug against TB

A group of scientists at the University of Manchester, UK has developed the first non-antibiotic drug to successfully tr...

September 12, 2018 | Wednesday | News
Genesys Spine launches AIS-C Stand-Alone System

Genesys Spine is pleased to announce the FDA clearance of our latest product line, the AIS-C Stand-Alone System. The AI...

September 11, 2018 | Tuesday | News
BloodCenter awarded $5 million NIH glycosciences grant

Singapore - BloodCenter of Wisconsin, part of Versiti, is among four academic and research centers which will recei...

September 10, 2018 | Monday | News
UK regulator declines Roche MS drug

Singapore - The UK's National Institute for Health and Care Excellence rejected Roche's OCREVUS (ocrelizumab) for p...

September 10, 2018 | Monday | News
Medivir appoints new CMO

Singapore - Medivir AB announced it has appointed Linda Basse as Chief Medical Officer effective October ...

September 10, 2018 | Monday | News
Oryzon gets approval for conducting Phase IIa trial of Vafidemstat

Oryzon Genomics, a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseas...

September 10, 2018 | Monday | News
Cytogel Pharma brings Alan W. Dunton on Board

Dean Maglaris, CEO of Cytogel Pharma has announced that Alan W. Dunton, M.D. has been named to the Board of Cytogel.&nbs...

September 10, 2018 | Monday | News
Samsung opens new AI centre in New York

Samsung Electronics is all set to open a new artificial intelligence (AI) research centre in New York City, U.S., to str...

September 10, 2018 | Monday | News